And research shows that sulforaphane can decrease neuroinflammation.[8] Sulforaphane also has neuroprotective benefits
doi: 10.1016/j.cgh.2023.06.004 Summary Keywords glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 receptor, type 2 diabetes, metabolic dysfunction-associated steatohepatitis, obesity Citation Oe Y, Omori T, Aimono E, Furukawa S, Kitakawa H, Tateno M, Sakai K and Cho KY (2025) Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide
If the patient meets the eligibility requirements and the medicine is deemed appropriate for managing their weight, they can be prescribed Wegovy
A., Tabeie, F., Tavakoli, S., & Khalili, S
A plateau usually means the body is finding a new balance, not that the treatment has stopped working